The IPO market has ignited for the first week of June, with five large initial public offerings slated to price this week. The market took a long road to get back to normal levels since the coronavirus pandemic-induced market crash back in March that had brought an anticipated busy season to a grinding halt. Following the shortened holiday week last week, the IPO market has stoked its old flame to add many new filings to excite the market for a busy summer season.

Starting the busy week, Warner Music Group Corp. plans to raise $2 billion from 70 million shares offered at an estimated $23-$26 per share. The record label giant is the world's third largest record company and music producer, being profitable even in the age of music streaming platforms. The company's IPO is the largest IPO for the year to date.

ZoomInfo Technologies Inc., a SaaS platform for sales and marketing data, plans to raise $921 million from 44.5 million shares offered at $16-$18 each. In addition the the large anticipated offering amount, the company has demonstrated profitability by reporting a revenue growth of 103% in 2019.

For investor-popular biotechs, Legend Biotech Corp. plans to raise about $424 million from 18.4 million shares offered between $18-$20 each, making it the largest biotech of the year. The clinical-stage oncology company lead candidate is a chimeric antigen receptor T cell therapy that is being developed jointly with Janssen Biotech, a subsidiary of Johnson & Johnson (JNJ  ). Pliant Therapeutics, Inc. aims to raise a whopping $110 million from 6 million shares priced between $14-$16 each. The company's lead candidate is a therapy for idiopathic pulmonary fibrosis, which is in phase two study. The company is also developing a therapy with Novartis (NVS  ). Lastly, Lantern Pharma Inc plans to raise $30.6 million from 1.56 million shares offered between $15-$17 each. The clinical stage biotech is focused on using artificial intelligence, machine learning and genomic data for oncology therapies.